Treatment of hepatitis C in hemodialysis patients using pegylated interferon alpha-2a in Turkey.

Purpose: Hepatitis C virus (HCV) is prevalent in renal insufficient patients. The aim of the present study was to evaluate the efficacy and tolerability of pegylated interferon alpha-2a (peg-IFN-alpha-2a) among these patients.

Methods: Among 437 patients within total hemodialysis population in hemodialysis units, in total 83 patients (19.